This is the first part in Understanding UTIs, an accessible series about urinary tract infections, including their symptoms, causes, medications and more.
This New York Times video showcases Stanford Medicine's efforts to offer COVID-19 antibody tests to its doctors, nurses and other clinical workers.
Stanford cardiologist Rahul Sharma spent nearly a month in quarantine after a mild case of COVID-19. He describes how the experience changed him.
The Stanford Clinical Virology Laboratory is ramping up capacity for its coronavirus diagnostic test, which can deliver results in 24 hours.
Scientists have used CRISPR-Cas9 screens to reveal more about how the bacteria behind Legionnaire's disease infects humans.
Scientists found a sneaky way to stop cold viruses from replicating in mammalian cells by disabling a protein not in the virus but in the cells they infect.
A Stanford study investigates the barriers to controlling parasitic disease and possible interventions beyond mass drug and education campaigns.
Stanford researchers watch in real time bacteria building their protective outer shell. Their findings may help develop treatments for bacterial pathogens.
The parasite that causes malaria is remarkably adept at developing resistance to the drugs devised to combat it. But new research suggests a solution.
Stanford researchers are using lab-grown heart cells to investigate how Chagas disease, which is spread by "kissing bugs," affects heart health.
Stanford researchers have developed a technique to encourage the immune system to target a section of the flu virus that is conserved year to year.
Scientists at Stanford and beyond are working toward a new type of tuberculosis diagnostic that utilizes blood samples.
Infectious disease expert Desiree LaBeaud is mapping outbreaks of Zika, dengue and chikungunya, three viral diseases transmitted by the same mosquitoes.
For babies in developing countries, pneumonia vaccines seem to work better if their mothers receive treatment for parasitic infections during pregnancy.
Writer Amy Adams reflects on her own experience with measles, and her lingering fears that she may have spread the virus to someone who was vulnerable.
A Stanford study shows Hsp70 protein inhibitors can protect mice from Zika virus without developing drug resistance, demonstrating their clinical potential.